Lumen Bioscience Strengthens Leadership Team to Advance Oral Biologics Pipeline
US-based clinical-stage biotech Lumen Bioscience, which develops orally delivered biologics, has announced key leadership enhancements as it advances its portfolio toward commercial launch.
Lumen Bioscience | 09/10/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy